THE TIME IS NOW FOR EUROPEAN HTA: HOW WILL THE EVOLUTION OF EUROPEAN HTA IMPACT ACCESS TO INNOVATIVE MEDICINES?

被引：0
|
作者：
Laisne, E. [1 ]
Allen, N. [1 ]
Kolotourou, K. [1 ]
Sattler-Ermacora, P. [1 ]
Grosvenor, A. [1 ]
机构：
[1] Precis Xtract, London, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP301
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [1] The evolution of European HTA and access to innovative medicines
    Kolotourou, Kate
    Ermacora, Petra
    Grosvenor, Alexander
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (05) : 275 - 278
  • [2] EUnetHTA -: European network for HTA
    Maekelae, Marjukka
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2007, 17 : 86 - 87
  • [3] THE IMPACT OF COVID-19 ON EUROPEAN HTA DECISIONS
    Watson, C.
    Petrie, J. L.
    Toomey, J. A.
    Shaw, C.
    VALUE IN HEALTH, 2022, 25 (01) : S183 - S183
  • [4] THE EVOLUTION AND COMPARISON OF HTA ASSESMENT ORGANISATIONS IN SELECTED EUROPEAN COUNTRIES
    Beletsi, A.
    Koutrafouri, V
    Karampli, E.
    Pavi, E.
    VALUE IN HEALTH, 2016, 19 (07) : A449 - A449
  • [5] DOES THE EUROPEAN UNION (EU) NEED EUROPEAN HTA OR EUROPEAN PROCUREMENT?
    Toumi, M.
    Remuzat, C.
    Auquier, P.
    Borrisov, B.
    Espin, J.
    Postma, M. J.
    Ruggeri, M.
    Wilk, N.
    Simoens, S.
    VALUE IN HEALTH, 2018, 21 : S85 - S85
  • [6] TIME TO HTA ASSESSMENT COMPLETION BY HTA AGENCY ARCHETYPE: FIVE-YEAR REVIEW FOR 20 EUROPEAN COUNTRIES
    Izmirlieva, M. A.
    VALUE IN HEALTH, 2023, 26 (12) : S329 - S329
  • [7] INNOVATIVE ACCESS PATHWAYS FOR DIGITAL HEALTHCARE SOLUTIONS: LEARNINGS FROM A EUROPEAN ANALOGUE ANALYSIS FOR ASIAN HTA BODIES
    Barzey, V
    Brennan, J.
    Tutt, S.
    Cope, N.
    VALUE IN HEALTH, 2018, 21 : S73 - S73
  • [8] ACCESS TO MEDICINES IN THE UNITED KINGDOM: A REVIEW OF HTA DECISIONS FOR NEW MEDICINES
    Abbas, N.
    Hasan, S. S.
    Babar, Z. U. D.
    VALUE IN HEALTH, 2020, 23 : S665 - S665
  • [9] EXPEDITED REGULATORY REVIEW AND AUTHORISATION OF MEDICINES AND THEIR SUBSEQUENT APPRAISAL BY HTA AGENCIES IN THE EUROPEAN UNION
    McCarron, C.
    Griebsch, I
    VALUE IN HEALTH, 2014, 17 (07) : A412 - A412
  • [10] HTA REQUIREMENTS IN CENTRAL EASTERN EUROPEAN COUNTRIES
    Augustynska, J.
    Skora, K.
    Leszczynska, A.
    Seweryn, M.
    VALUE IN HEALTH, 2022, 25 (12) : S326 - S326
12345